Balanced news tone
News Sentiment
SAN sentiment intelligence
Sanofi news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
46
Balanced news tone
23 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-3.2% over one week, -3.6% over four weeks, trend inactive, and near fair-value range.
Sanofi (ENXTPA:SAN) Stock Sees Modest Fair Value Cut As Analysts Revise Valuation Assumptions
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
-3.2%
Price reacting lower
Trend fit
Trend inactive
-3.6% over four weeks
Fair value
-9.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
16
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Sanofi (ENXTPA:SAN) Stock Sees Modest Fair Value Cut As Analysts Revise Valuation Assumptions
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Jun 2026 03:16
- Source
- Market source
Market source
Direct company coverage
Sanofi: Information concerning the total number of voting rights and shares – May 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 16:05
- Source
- Market source
Market source
Direct company coverage
Sanofi (ENXTPA:SAN) Stock After Mixed CIDP Trial Halt And Sarclisa EU Approval How Does Valuation Look Now
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 14 Jun 2026 20:06
- Source
- Market source
simplywall.st
Direct company coverage
Sanofi (ENXTPA:SAN) Stock Valuation Check After Mixed Returns And Undervaluation Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 06:15
- Source
- simplywall.st
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000127771): employee share plan launch and valuation metrics in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000120578): analyst consensus steady as ADRs trade in low-40s USD range
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 01 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000127771): Technical picture and price action on Euronext Paris
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000127771): Insider and ownership profile in focus as shares trade steadily in
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000120578): FDA priority review underpins pipeline focus ahead of key 2026 dec
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Sanofi S.A. stock (FR0000120578): FDA priority review keeps pipeline in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- AD HOC NEWS
Sharecast.com
Direct company coverage
Sanofi shares jump on solid Q1 ahead of new CEO arrival
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Sharecast.com
Market source
Direct company coverage
Sanofi: Information concerning the total number of voting rights and shares - March 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors (SNY)
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 16 Mar 2026 07:00
- Source
- Seeking Alpha
Reuters
Direct company coverage
Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- Reuters
Capital.com
Direct company coverage
Sanofi Stock Forecast 2026–2030 | Future Outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jan 2026 08:00
- Source
- Capital.com
MarketWatch
Direct company coverage
Sanofi stock slumps after two setbacks on multiple-sclerosis drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Dec 2025 08:00
- Source
- MarketWatch
Reuters
Direct company coverage
Sanofi flags second delay to FDA decision on multiple sclerosis drug, shares fall
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Dec 2025 08:00
- Source
- Reuters
WSJ
Direct company coverage
Sanofi Shares Fall After Multiple Sclerosis Drug Gets Hit by Double Setback
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Dec 2025 08:00
- Source
- WSJ
Investor's Business Daily
Direct company coverage
Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 26 Nov 2025 08:00
- Source
- Investor's Business Daily
Investing.com
Direct company coverage
Sanofi headquarters searched in French tax fraud probe - Le Monde
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 25 Nov 2025 08:00
- Source
- Investing.com
Reuters
Direct company coverage
Sanofi sheds $13 billion in value on weak trial results for eczema drug
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 04 Sep 2025 07:00
- Source
- Reuters
CNBC
Direct company coverage
Sanofi loses $21 billion in market value after dropping 2025 profit target
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Oct 2023 07:00
- Source
- CNBC
Fierce Pharma
Direct company coverage
Sanofi CEO Paul Hudson's new 'Play to Win' pivot sends stock plunging
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Oct 2023 07:00
- Source
- Fierce Pharma